BriaCell Long Term Investments vs Short Long Term Debt Analysis

Stocks . USA . 
Stock . BriaCell Therapeutics Corp
BCTXW Stock  USD 0.34  0.06  18.97%   
BriaCell Therapeutics financial indicator trend analysis is way more than just evaluating BriaCell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BriaCell Therapeutics is a good investment. Please check the relationship between BriaCell Therapeutics Long Term Investments and its Short Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Long Term Investments vs Short Long Term Debt

Long Term Investments vs Short Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BriaCell Therapeutics Long Term Investments account and Short Long Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between BriaCell Therapeutics' Long Term Investments and Short Long Term Debt is -0.45. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of BriaCell Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of BriaCell Therapeutics' Long Term Investments and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of BriaCell Therapeutics Corp are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Long Term Investments i.e., BriaCell Therapeutics' Long Term Investments and Short Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.45
Relationship DirectionNegative 
Relationship StrengthVery Weak

Long Term Investments

Long Term Investments is an item on the asset side of BriaCell Therapeutics balance sheet that represents investments BriaCell Therapeutics intends to hold for over a year. BriaCell Therapeutics Corp long term investments may include different instruments such as stocks, bonds, real estate and cash.

Short Long Term Debt

The total of a company's short-term and long-term borrowings.
Most indicators from BriaCell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BriaCell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
At this time, BriaCell Therapeutics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 8.4 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.62) in 2024.
 2021 2022 2023 2024 (projected)
Interest Income136.7K891.2K1.0M1.1M
Research Development8.0M15.3M27.2M28.5M

BriaCell Therapeutics fundamental ratios Correlations

Total Assets
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Shares Outstanding
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Net Receivables
Other Current Liab
Property Plant And Equipment Net
Inventory
Other Current Assets
Intangible Assets
Current Deferred Revenue
Net Invested Capital
Long Term Investments
Net Working Capital
Short Long Term Debt Total
Total Assets
-0.10.79-0.98-0.33-0.010.98-0.04-0.10.980.450.540.70.520.980.02-0.15-0.050.090.350.42-0.440.79-0.080.97-0.57
Total Current Liabilities
-0.1-0.290.17-0.750.93-0.18-0.080.93-0.190.68-0.070.010.12-0.140.90.2-0.23-0.930.220.41-0.53-0.240.93-0.27-0.59
Total Stockholder Equity
0.79-0.29-0.80.18-0.20.80.09-0.210.8-0.06-0.060.87-0.10.77-0.26-0.180.110.22-0.140.17-0.130.98-0.20.78-0.21
Net Debt
-0.980.17-0.80.240.11-1.00.190.19-1.0-0.37-0.52-0.65-0.49-1.00.090.10.18-0.18-0.3-0.430.42-0.830.17-0.990.55
Retained Earnings
-0.33-0.750.180.24-0.79-0.240.13-0.7-0.23-0.98-0.56-0.06-0.7-0.3-0.860.030.260.72-0.66-0.520.650.13-0.71-0.20.79
Accounts Payable
-0.010.93-0.20.11-0.79-0.110.020.99-0.120.75-0.030.080.13-0.070.97-0.16-0.13-0.990.20.27-0.42-0.170.99-0.19-0.53
Cash
0.98-0.180.8-1.0-0.24-0.11-0.19-0.191.00.360.520.650.491.0-0.1-0.1-0.180.180.30.44-0.430.83-0.180.99-0.54
Non Current Assets Total
-0.04-0.080.090.190.130.02-0.190.04-0.19-0.13-0.170.27-0.19-0.20.01-0.220.98-0.03-0.2-0.330.32-0.120.04-0.190.25
Non Currrent Assets Other
-0.10.93-0.210.19-0.70.99-0.190.04-0.20.67-0.150.050.02-0.160.93-0.16-0.11-0.990.090.24-0.38-0.181.0-0.27-0.44
Cash And Short Term Investments
0.98-0.190.8-1.0-0.23-0.121.0-0.19-0.20.350.520.650.491.0-0.11-0.11-0.180.190.290.43-0.420.83-0.180.99-0.53
Common Stock Shares Outstanding
0.450.68-0.06-0.37-0.980.750.36-0.130.670.350.620.110.730.420.81-0.14-0.24-0.680.610.49-0.63-0.020.680.32-0.79
Non Current Liabilities Total
0.54-0.07-0.06-0.52-0.56-0.030.52-0.17-0.150.520.62-0.090.980.560.11-0.03-0.160.130.710.34-0.37-0.03-0.140.56-0.46
Other Stockholder Equity
0.70.010.87-0.65-0.060.080.650.270.050.650.11-0.09-0.080.640.06-0.110.24-0.080.10.11-0.130.810.070.62-0.27
Total Liab
0.520.12-0.1-0.49-0.70.130.49-0.190.020.490.730.98-0.080.540.270.04-0.22-0.040.760.42-0.48-0.070.030.51-0.59
Total Current Assets
0.98-0.140.77-1.0-0.3-0.071.0-0.2-0.161.00.420.560.640.54-0.04-0.1-0.190.150.370.45-0.450.8-0.140.99-0.57
Net Receivables
0.020.9-0.260.09-0.860.97-0.10.010.93-0.110.810.110.060.27-0.04-0.14-0.13-0.930.410.3-0.45-0.230.93-0.15-0.57
Other Current Liab
-0.150.2-0.180.10.03-0.16-0.1-0.22-0.16-0.11-0.14-0.03-0.110.04-0.1-0.14-0.210.120.120.25-0.24-0.16-0.15-0.14-0.22
Property Plant And Equipment Net
-0.05-0.230.110.180.26-0.13-0.180.98-0.11-0.18-0.24-0.160.24-0.22-0.19-0.13-0.210.13-0.23-0.410.41-0.1-0.11-0.170.35
Inventory
0.09-0.930.22-0.180.72-0.990.18-0.03-0.990.19-0.680.13-0.08-0.040.15-0.930.120.13-0.13-0.220.360.19-0.990.260.45
Other Current Assets
0.350.22-0.14-0.3-0.660.20.3-0.20.090.290.610.710.10.760.370.410.12-0.23-0.130.28-0.35-0.10.10.33-0.46
Intangible Assets
0.420.410.17-0.43-0.520.270.44-0.330.240.430.490.340.110.420.450.30.25-0.41-0.220.28-0.980.260.230.38-0.79
Current Deferred Revenue
-0.44-0.53-0.130.420.65-0.42-0.430.32-0.38-0.42-0.63-0.37-0.13-0.48-0.45-0.45-0.240.410.36-0.35-0.98-0.21-0.37-0.370.87
Net Invested Capital
0.79-0.240.98-0.830.13-0.170.83-0.12-0.180.83-0.02-0.030.81-0.070.8-0.23-0.16-0.10.19-0.10.26-0.21-0.180.81-0.27
Long Term Investments
-0.080.93-0.20.17-0.710.99-0.180.041.0-0.180.68-0.140.070.03-0.140.93-0.15-0.11-0.990.10.23-0.37-0.18-0.25-0.47
Net Working Capital
0.97-0.270.78-0.99-0.2-0.190.99-0.19-0.270.990.320.560.620.510.99-0.15-0.14-0.170.260.330.38-0.370.81-0.25-0.48
Short Long Term Debt Total
-0.57-0.59-0.210.550.79-0.53-0.540.25-0.44-0.53-0.79-0.46-0.27-0.59-0.57-0.57-0.220.350.45-0.46-0.790.87-0.27-0.47-0.48
Click cells to compare fundamentals

BriaCell Therapeutics Account Relationship Matchups

High Positive Relationship

Cash And Short Term Investments
+ 1.0
Cash
Total Current Assets
+ 1.0
Cash
Long Term Investments
+ 1.0
Non Currrent Assets Other
Total Current Assets
+ 1.0
Cash And Short Term Investments
Non Currrent Assets Other
+ 0.99
Accounts Payable
Long Term Investments
+ 0.99
Accounts Payable

High Negative Relationship

Total Current Assets
- 1.0
Net Debt
Cash And Short Term Investments
- 1.0
Net Debt
Cash
- 1.0
Net Debt
Long Term Investments
- 0.99
Inventory
Inventory
- 0.99
Non Currrent Assets Other
Inventory
- 0.99
Accounts Payable

BriaCell Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets478.3K58.0M42.6M27.2M5.9M10.3M
Total Current Liabilities3.6M556.8K941.1K1.8M7.5M7.8M
Total Stockholder Equity(3.3M)57.3M10.3M(3.8M)(2.4M)(2.3M)
Net Debt209.3K(57.2M)(41.0M)(21.3M)(862.1K)(905.2K)
Retained Earnings(16.6M)(15.8M)(60.3M)(80.7M)(85.4M)(81.2M)
Accounts Payable4.2K214.1K463.3K1.1M7.2M7.5M
Cash19.5K57.3M41.0M21.3M862.1K819.0K
Non Current Assets Total238.9K245.6K230.3K215.1K2.2M1.2M
Cash And Short Term Investments19.5K57.3M41.0M21.3M862.1K819.0K
Common Stock Shares Outstanding713.9K4.5M15.5M15.5M16.5M17.3M
Liabilities And Stockholders Equity478.3K58.0M42.6M27.2M5.9M10.3M
Non Current Liabilities Total142.8K225.4K31.3M29.1M1.1M1.0M
Other Stockholder Equity2.2M31.8M5.2M7.4M11.0M7.7M
Total Liab3.8M782.2K32.2M30.9M8.6M4.8M
Total Current Assets239.4K57.8M42.3M26.9M3.7M3.5M
Net Receivables20.6K12.6K24.1K717.7K1.4M1.4M
Other Current Liab3.4M342.7K477.8K677.7K290.4K275.9K
Inventory(305.0)1.0(24.1K)(18.9K)(1.4M)(1.3M)
Other Current Assets199.7K516.9K1.3M5.0M1.4M721.5K
Accumulated Other Comprehensive Income(81.0K)(94.5K)(127.0K)(138.7K)(124.8K)(118.6K)
Intangible Assets238.9K245.6K230.3K215.1K199.8K182.9K
Net Invested Capital(4.1M)57.3M10.3M(3.8M)(2.4M)(2.3M)
Net Working Capital(4.5M)57.2M41.4M25.1M(3.8M)(3.6M)
Capital Stock11.2M54.8M65.6M69.6M72.2M45.8M
Common Stock11.2M54.8M65.6M69.6M72.2M45.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for BriaCell Stock Analysis

When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY